TCL Archive In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford March 11, 1977
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer January 25, 2008
TCL Archive Scientists, Industry Identify Barriers To Development of Molecular Therapies April 12, 2002
